1. Home
  2. GP vs ALZN Comparison

GP vs ALZN Comparison

Compare GP & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GreenPower Motor Company Inc.

GP

GreenPower Motor Company Inc.

HOLD

Current Price

$1.37

Market Cap

6.7M

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

N/A

Current Price

$1.67

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GP
ALZN
Founded
2010
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
7.5M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
GP
ALZN
Price
$1.37
$1.67
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
239.9K
69.6K
Earning Date
02-12-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
76.77
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.84
52 Week High
$4.00
$2.68

Technical Indicators

Market Signals
Indicator
GP
ALZN
Relative Strength Index (RSI) 52.80 68.02
Support Level $1.48 $1.04
Resistance Level $1.80 $2.25
Average True Range (ATR) 0.11 0.09
MACD -0.01 0.01
Stochastic Oscillator 35.04 100.00

Price Performance

Historical Comparison
GP
ALZN

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.

Share on Social Networks: